Article
Radiology, Nuclear Medicine & Medical Imaging
Xue-Song Sun, Zhi-Wen Xiao, Sai-Lan Liu, Rui Sun, Dong-Hua Luo, Qiu-Yan Chen, Hai-Qiang Mai
Summary: This study developed and validated a nomogram model to predict the overall survival of patients with nasopharyngeal carcinoma without distant metastasis. The model incorporates clinical characteristics, serum biomarkers, and the presence of nasopharyngeal necrosis.
EUROPEAN RADIOLOGY
(2023)
Article
Biochemistry & Molecular Biology
Kyle S. Draleau, Faycal Chettibi, Chafia Touil-Boukoffa, Djamel Djennaoui, Taha Merghoub, Mehdi Bourouba, Ahmed Amine Zergoun
Summary: In this study, the plasmatic secretomes of NPC untreated and relapsing patients were analyzed to identify novel prognostic biomarkers. The results showed upregulation of certain cytokines in untreated and relapsing patients. There were also correlations found between different cytokines in different patient groups. The study suggests that the High IL-8/Low NO signature may be a predictor of poor prognosis for NPC patients.
Article
Radiology, Nuclear Medicine & Medical Imaging
Fan Yang, Xiaolu Li, Yujie Li, Huizi Lei, Qiang Du, Xiaoduo Yu, Lin Li, Yanfeng Zhao, Lizhi Xie, Meng Lin
Summary: Our study found that histogram parameters derived from synthetic magnetic resonance imaging (SyMRI) were positively correlated with prognostically relevant factors in nasopharyngeal carcinoma (NPC). These results suggest that these histogram parameters have potential value in assessing the expression levels of Ki-67 and EGFR, histological type, EBV DNA level, EA-IgA, and tumor stage in NPC.
EUROPEAN RADIOLOGY
(2023)
Article
Oncology
Shixiong Wu, Cen Zhang, Jing Xie, Shuang Li, Shuo Huang
Summary: A prognostic signature based on five microRNAs was constructed to accurately predict the prognosis of nasopharyngeal carcinoma. Patients were divided into high- and low-risk groups based on risk scores calculated by the LASSO algorithm, with those in the high-risk group showing worse prognosis outcomes and chemotherapy responses. Time-dependent receiver operating characteristic curve analysis demonstrated high accuracy in predicting 1-year overall survival rates for the five-microRNA signature.
FRONTIERS IN ONCOLOGY
(2021)
Article
Oncology
Jia-Lin Ma, Shi-Ting Huang, Yan-Ming Jiang, Xin-Bin Pan
Summary: The study found that radiotherapy alone is recommended for stage I nasopharyngeal carcinoma patients, as it showed better survival rates compared to chemoradiotherapy. Chemoradiotherapy was associated with worse overall survival and cancer-specific survival outcomes in these patients.
FRONTIERS IN ONCOLOGY
(2021)
Article
Otorhinolaryngology
Katelyn O. Stepan, Angela L. Mazul, S. Andrew Skillington, Randal C. Paniello, Jason T. Rich, Jose P. Zevallos, Ryan S. Jackson, Patrik Pipkorn, Sean Massa, Sidharth Puram
Summary: This retrospective cohort study utilizing the National Cancer Database from 2004 to 2016 found that race has variable prognostic importance in nasopharyngeal carcinoma (NPC) and the significance varies across histological subtypes. The study showed that among different ethnic groups, survival rates differed depending on the histological subtype of NPC.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
(2021)
Article
Oncology
Hao Peng, Lei Chen, Yan-Ping Mao, Li Tian, Li-Zhi Liu
Summary: This study investigated the efficacy of TPF, TP, and PF induction chemotherapy regimens for nasopharyngeal carcinoma patients with different risk levels. Results showed that TPF was more effective for high-risk patients, while PF may be a better option for low-risk patients due to lower toxicities.
Review
Cell Biology
Jiali Zhang, Defa Huang, Xianbin Lan, Dongming Deng, Jijing Li, Dongzhi Zhang, Yue Li, Tianyu Zhong, Shaoping Peng
Summary: Nasopharyngeal carcinoma (NPC) is a malignant tumor that originates from the epithelium of the nasopharynx. Early diagnosis of NPC is crucial to improve prognosis, and small extracellular vesicles (sEVs) have shown potential as biomarkers for malignancy detection in NPC. This review summarizes the application of sEVs as biomarkers in NPC diagnosis, their role in NPC metastasis and prognosis, and discusses future applications and limitations.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2023)
Article
Cell Biology
Yunqin Chen, Zhen Wang, Hong Li, Yixue Li
Summary: This study identified a 6-miRNA prognostic signature in nasopharyngeal carcinoma, which showed good prediction capability in terms of overall survival, disease-free survival, and metastasis-free survival. The 6-miRNA risk score may be useful for clinicians in treatment strategies and predicting patient outcomes.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2021)
Article
Pharmacology & Pharmacy
Shan-Shan Guo, Yu-Jing Liang, Li-Ting Liu, Qiu-Yan Chen, Yue-Feng Wen, Sai-Lan Liu, Xue-Song Sun, Qing-Nan Tang, Xiao-Yun Li, Hai-Qiang Mai, Lin-Quan Tang
Summary: The study identified Angiogenin (ANG) as a potential molecular marker for predicting tumor recurrence and progression in nasopharyngeal carcinoma (NPC) patients. Increased expression of ANG was associated with radioresistance and poor prognosis in NPC. A nomogram model based on ANG expression was developed to predict overall survival in NPC patients.
FRONTIERS IN PHARMACOLOGY
(2021)
Article
Medicine, Research & Experimental
Yali Xu, Taoyuan Huang, Min Mao, Jinming Zhai, Jinhai Chen
Summary: The study evaluated prognostic factors and distant metastatic patterns in de novo metastatic nasopharyngeal carcinoma patients, with liver metastasis identified as an independent predictor for poor cancer-specific survival and overall survival.
Article
Endocrinology & Metabolism
Zhijie Fang, Hua Huang, Liyu Wang, Zhiqiang Lin
Summary: This study investigates the role of metabolic pathways in nasopharyngeal carcinoma (NPC) and identifies genes associated with alpha linolenic acid metabolism. The study constructs an effective prognosis model and suggests that certain patients may be more sensitive to immunotherapy and lapatinib.
FRONTIERS IN ENDOCRINOLOGY
(2022)
Review
Oncology
Kazi Anisha Islam, Larry Ka-Yue Chow, Ngar Woon Kam, Ying Wang, Chi Leung Chiang, Horace Cheuk-Wai Choi, Yun-Fei Xia, Anne Wing-Mui Lee, Wai Tong Ng, Wei Dai
Summary: This study investigates molecular biomarkers for prognostic prediction in patients with nasopharyngeal carcinoma (NPC). Seventeen important markers are identified, including genetic polymorphisms, methylation, microRNAs, mutation, and gene expression panels. These biomarkers can be used to predict patient survival and guide personalized therapy. The study also highlights the clinical need for a comprehensive evaluation of multiple types of biomarkers in a multicenter study, and these biomarkers are involved in various signaling pathways that could be potential therapeutic targets.
Article
Medicine, General & Internal
Dan-Ning Dong, Pei-Wen Fan, Ya-Ning Feng, Gui-Hai Liu, Yan-Chun Peng, Tao Dong, Ruo-Zheng Wang, Jin-Ming Yu
Summary: In patients with nasopharyngeal carcinoma, high expression of circulating CD39+CD8+ T cells is associated with a reduced risk of distant metastasis and improved progression-free survival.
CHINESE MEDICAL JOURNAL
(2021)
Article
Biochemistry & Molecular Biology
Wei-Chieh Lin, Yu-Hung Kuo, Chuan-Jen Hsu, Hung-Pin Wu, Yuan-Jhen Hsu
Summary: This study investigated the role of rhinosinusitis severity in the prognosis of patients with nasopharyngeal carcinoma (NPC). The results showed that worsening rhinosinusitis was a predictor of poor prognosis.